MLYS Mineralys Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 11, 2026
$23,63
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$22,30rendah 52m
$47,65tinggi 52m
Kapitalisasi Pasar (MRQ)
$2.09B
P/E
-10.4
EPS
$-2.29
lencana Anda
Rentang 52M
$22–$48
Peringkat Analis
BUY
Target Harga
$48
P/E
-10.4
ROE
-32.2%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
MLYS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$23.63
Kapitalisasi Pasar (MRQ)
$2.09B
P/E
-10.4
EPS
$-2.29
ROE
-32.2%
Rentang 52M
$22–$48
MLYS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-2.292022-12-31 → 2025-12-31
Arus Kas Bebas$-142M2024-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | MLYS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -10.4rata-rata 5T ≈-7.8 | ≈-7.8 | · | · | |
| P/B (MRQ) | 3.8rata-rata 5T ≈3.1 | ≈3.1 | 5.4 | Kurang nilai | |
| Price / FCF (Harga / FCF) | -13.7 | · | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -13.7rata-rata 5T ≈-9.6 | ≈-9.6 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 3.0rata-rata 5T ≈3.1 | ≈3.1 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | MLYS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -35.6%rata-rata 5T ≈-50.9% | ≈-50.9% | -39.4% | Sejajar | |
| ROE | -32.2%rata-rata 5T ≈-47.9% | ≈-47.9% | -59.4% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | MLYS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 34.5rata-rata 5T ≈27.2 | ≈27.2 | 8.5 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 11.4rata-rata 5T ≈8.0 | ≈8.0 | 4.5 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-57.8%
Laporan Berikutnya
Nov 09, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 18, 2026 | $-2.85 | $-0.55 | -422.3% |
| 31 Maret 2026 | Mei 18, 2026 | $-0.47 | $-0.47 | 0.11% |
| 31 Des. 2025 | $-0.40 | $-0.54 | 26.4% | |
| 30 Sep. 2025 | $-0.52 | $-0.63 | 17.8% | |
| 30 Juni 2025 | $-0.66 | $-0.73 | 10.1% | |
| 31 Maret 2025 | $-0.79 | $-1.00 | 21.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $132M | $169M | $70M | $26M | |
| SG&A Expense | $39M | $24M | $14M | $5M | |
| Operating Expenses | $171M | $192M | $85M | $31M | |
| Operating Income | $-171M | $-192M | $-85M | $-31M | |
| Other Non-op | $0 | $5.0K | $3.0K | $2M | |
| Income Tax | $0 | · | · | · | |
| Net Income | $-155M | $-178M | $-72M | $-30M | |
| EPS (Basic) | $-2.29 | $-3.66 | $-1.99 | $-5.77 | |
| EPS (Diluted) | $-2.29 | $-3.66 | $-1.99 | $-5.77 | |
| Shares (Basic) | 67,656,355 | 48,539,795 | 36,188,254 | 5,167,296 | |
| Shares (Diluted) | 67,656,355 | 48,539,795 | 36,188,254 | 5,167,296 | |
| EBITDA | $-171M | $-192M | $-85M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $173M | $114M | $49M | $88M | |
| Prepaid Expense | $5M | $7M | $13M | $3M | |
| Current Assets | $661M | $205M | $249M | $113M | |
| PP&E (Net) | $38.0K | $53.0K | $0 | · | |
| Other Non-current Assets | $382.0K | $499.0K | $51.0K | $2M | |
| Total Assets | $662M | $206M | $252M | $114M | |
| Accounts Payable | $2M | $479.0K | $601.0K | $2M | |
| Accrued Liabilities | $13M | $14M | $10M | $6M | |
| Current Liabilities | $15M | $15M | $10M | $8M | |
| Total Liabilities | $15M | · | · | · | |
| Common Stock | $8.0K | $5.0K | $4.0K | $1.0K | |
| Paid-in Capital | $1.10B | $494M | $366M | $540.0K | |
| Retained Earnings | $-457M | $-303M | $-125M | $-53M | |
| Stockholders' Equity | $647M | $191M | $241M | $-52M | |
| Liabilities + Equity | $662M | $206M | $252M | $114M | |
| Shares Outstanding | 81,536,557 | 49,821,915 | 41,133,916 | 6,419,238 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $59.0K | $43.0K | $0 | · | |
| Stock-based Comp | $19M | $11M | $5M | $455.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | |
| Other Non-cash | $-7M | $117.0K | · | · | |
| Operating Cash Flow | $-142M | $-166M | $-81M | $-29M | |
| CapEx | $15.0K | $96.0K | $0 | · | |
| Investing Cash Flow | $-390M | $115M | $-160M | $-22M | |
| Financing Cash Flow | $591M | $116M | $203M | $128M | |
| Net Change in Cash | $59M | $65M | $-38M | $77M | |
| Free Cash Flow | $-142M | $-166M | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -35.6% | -77.7% | -39.3% | · | |
| ROE | -32.2% | -83.0% | -28.5% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 43.8 | 14.0 | 23.8 | · | |
| Quick Ratio | 11.4 | 7.8 | 4.7 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $7.93 | $3.84 | $5.86 | · | |
| Cash Flow / Share | $-2.10 | $-3.43 | $-2.24 | · | |
| Cash / Share | $2.12 | $2.29 | $1.20 | · | |
| EPS (TTM) | $-2.29 | $-3.66 | $-1.99 | $-5.77 |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-155M | $-178M | $-72M | $-30M | |
| Market Cap | $2.96B | $613M | $354M | · | |
| P/E | -15.8 | -3.4 | -4.3 | · | |
| P/B | 4.6 | 3.2 | 1.5 | · | |
| P / Tangible Book | 4.6 | 3.2 | 1.5 | · | |
| P / Cash Flow | -20.8 | -3.7 | -4.4 | · | |
| P / FCF | -20.8 | -3.7 | · | · | |
| Earnings Yield | -6.3% | -29.7% | -23.1% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $221M | $24M | $24M | $31M | $38M | $38M | $45M | $54M | $39M | $31M | $24M | $22M | $12M | $12M | $8M | $6M | |
| SG&A Expense | $25M | $21M | $14M | $10M | $8M | $7M | $7M | $6M | $6M | $5M | $4M | $4M | $4M | $3M | $2M | $1M | |
| Operating Expenses | $246M | $45M | $38M | $41M | $47M | $44M | $52M | $60M | $45M | $35M | $28M | $26M | $16M | $15M | $10M | $7M | |
| Operating Income | $-246M | $-45M | $-38M | $-41M | $-47M | $-44M | $-52M | $-60M | $-45M | $-35M | $-28M | $-26M | $-16M | $-15M | $-10M | $-7M | |
| Other Non-op | $13.0K | $5.0K | $1.0K | $4.0K | $-2.0K | $-3.0K | $12.0K | $-10.0K | $2.0K | $1.0K | $-6M | $0 | $4M | $2M | $935.0K | $745.0K | |
| Income Tax | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-241M | $-39M | $-32M | $-37M | $-43M | $-42M | $-49M | $-56M | $-41M | $-32M | $-24M | $-23M | $-12M | $-13M | $-9M | $-7M | |
| EPS (Basic) | $-2.85 | $-0.47 | $-0.32 | $-0.52 | $-0.66 | $-0.79 | $-1.00 | $-1.13 | $-0.83 | $-0.70 | $-0.60 | $-0.57 | $-0.31 | $-0.51 | $-1.74 | $-1.29 | |
| EPS (Diluted) | $-2.85 | $-0.47 | $-0.32 | $-0.52 | $-0.66 | $-0.79 | $-1.00 | $-1.13 | $-0.83 | $-0.70 | $-0.60 | $-0.57 | $-0.31 | $-0.51 | $-1.74 | $-1.29 | |
| Shares (Basic) | 84,727,282 | 82,834,752 | · | 70,594,504 | 65,451,297 | 53,163,551 | · | 49,815,186 | 49,356,287 | 44,900,755 | · | 39,930,748 | 39,754,981 | 24,764,469 | · | 5,181,410 | |
| Shares (Diluted) | 84,727,282 | 82,834,752 | · | 70,594,504 | 65,451,297 | 53,163,551 | · | 49,815,186 | 49,356,287 | 44,900,755 | · | 39,930,748 | 39,754,981 | 24,764,469 | · | 5,181,410 | |
| EBITDA | $-246M | $-45M | · | $-41M | $-47M | $-44M | · | $-60M | $-45M | $-35M | · | $-26M | $-16M | $-15M | · | · |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $138M | $113M | $173M | $218M | $102M | $165M | $114M | $97M | $68M | $90M | $49M | $86M | $101M | $138M | $88M | · | |
| Prepaid Expense | $4M | $6M | $5M | $6M | $10M | $11M | $7M | $4M | $7M | $8M | $13M | $12M | $8M | $5M | $3M | · | |
| Current Assets | $666M | $652M | $661M | $600M | $335M | $355M | $205M | $268M | $318M | $347M | $249M | $265M | $269M | $275M | $113M | · | |
| PP&E (Net) | $27.0K | $32.0K | $38.0K | $7.0K | $22.0K | $38.0K | $53.0K | $69.0K | $42.0K | $51.0K | $0 | · | · | · | · | · | |
| Other Non-current Assets | $2M | $360.0K | $382.0K | $144.0K | $433.0K | $397.0K | $499.0K | $452.0K | $449.0K | $379.0K | $51.0K | $51.0K | $51.0K | $39.0K | $2M | · | |
| Total Assets | $668M | $653M | $662M | $600M | $336M | $355M | $206M | $268M | $318M | $347M | $252M | $278M | $291M | $306M | $114M | · | |
| Accounts Payable | $1M | $1M | $2M | $1M | $3M | $373.0K | $479.0K | $3M | $2M | $4M | $601.0K | $6M | $2M | $2M | $2M | · | |
| Accrued Liabilities | $18M | $14M | $13M | $22M | $19M | $13M | $14M | $28M | $27M | $15M | $10M | $8M | $4M | $8M | $6M | · | |
| Current Liabilities | $19M | $15M | $15M | $24M | $22M | $13M | $15M | $31M | $28M | $19M | $10M | $14M | $6M | $11M | $8M | · | |
| Total Liabilities | $117M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | $100.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $9.0K | $8.0K | $8.0K | $8.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $1.0K | · | |
| Paid-in Capital | $1.29B | $1.13B | $1.10B | $1.00B | $702M | $686M | $494M | $490M | $487M | $484M | $366M | $364M | $363M | $361M | $540.0K | · | |
| Retained Earnings | $-738M | $-497M | $-457M | $-425M | $-388M | $-345M | $-303M | $-254M | $-197M | $-156M | $-125M | $-100M | $-78M | $-65M | $-53M | · | |
| Stockholders' Equity | $551M | $638M | $647M | $576M | $314M | $342M | $191M | $237M | $290M | $328M | $241M | $264M | $285M | $296M | $-52M | · | |
| Liabilities + Equity | $668M | $653M | $662M | $600M | $336M | $355M | $206M | $268M | $318M | $347M | $252M | $278M | $291M | $306M | $114M | · | |
| Shares Outstanding | 88,351,196 | 82,454,950 | 81,536,557 | 78,969,459 | 65,725,409 | 64,876,228 | 49,821,915 | 49,755,946 | 49,710,598 | 49,632,989 | 41,133,916 | 41,105,118 | 40,856,653 | 40,856,653 | 6,419,238 | · |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5.0K | $6.0K | $13.0K | $15.0K | $16.0K | $15.0K | $15.0K | $11.0K | $9.0K | $8.0K | $0 | $0 | $0 | $0 | · | · | |
| Stock-based Comp | $7M | $7M | $5M | $6M | $5M | $4M | $3M | $3M | $3M | $2M | $1M | $2M | $1M | $749.0K | $218.0K | $192.0K | |
| Other Non-cash | · | $-7M | · | · | · | $-7M | · | · | · | $10M | · | · | · | · | · | · | |
| Operating Cash Flow | $-33M | $-39M | $-38M | $-29M | $-30M | $-45M | $-67M | $-50M | $-30M | $-19M | $-29M | $-19M | $-20M | $-13M | $-10M | $-7M | |
| CapEx | · | · | $15.0K | $0 | $0 | $0 | $0 | $37.0K | $0 | $59.0K | $0 | $0 | $0 | $0 | · | · | |
| Investing Cash Flow | $-185M | $-45M | $-103M | $-151M | $-43M | $-93M | $84M | $80M | $8M | $-56M | $-8M | $4M | $-16M | $-140M | $50M | $-72M | |
| Stock Issued | · | · | · | · | · | $189M | · | · | · | $0 | · | $0 | $-581.0K | $204M | · | $-561.0K | |
| Net Stock Activity | · | · | · | · | · | $189M | · | · | · | · | · | · | · | $204M | · | · | |
| Financing Cash Flow | $243M | $24M | $97M | $295M | $10M | $189M | $90.0K | $-1.0K | $-152.0K | $116M | $74.0K | $184.0K | $-581.0K | $204M | $-1M | $-561.0K | |
| Net Change in Cash | $25M | $-60M | $-45M | $116M | $-63M | $51M | $17M | $29M | $-23M | $41M | $-37M | $-15M | $-37M | $51M | $39M | $-79M | |
| Free Cash Flow | · | · | · | · | · | $-45M | · | · | · | $-19M | · | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -48.0% | -7.8% | · | -8.5% | -13.2% | -12.0% | · | -20.6% | -13.5% | -9.6% | · | -16.4% | -8.3% | -8.2% | · | · | |
| ROE | -55.8% | -8.0% | · | -9.1% | -14.3% | -12.6% | · | -22.5% | -14.3% | -10.1% | · | -17.2% | -8.5% | -8.5% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 34.5 | 44.3 | · | 25.5 | 15.1 | 26.5 | · | 8.5 | 11.2 | 18.1 | · | 19.6 | 43.4 | 26.1 | · | · | |
| Quick Ratio | 7.2 | 7.7 | · | 9.3 | 4.6 | 12.3 | · | 3.1 | 2.4 | 4.7 | · | 6.4 | 16.3 | 13.1 | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.24 | $7.74 | · | $7.30 | $4.77 | $5.26 | · | $4.76 | $5.84 | $6.61 | · | $6.42 | $6.98 | $7.24 | · | · | |
| Cash Flow / Share | · | $-0.48 | · | · | · | $-0.86 | · | · | · | $-0.43 | · | · | · | $-0.52 | · | · | |
| Cash / Share | $1.56 | $1.37 | · | $2.76 | $1.55 | $2.54 | · | $1.96 | $1.36 | $1.82 | · | $2.10 | $2.48 | $3.38 | · | · | |
| EPS (TTM) | $-4.16 | $-1.97 | · | $-2.97 | $-3.58 | $-3.75 | · | $-3.26 | $-2.70 | $-2.18 | · | $-3.13 | $-3.85 | $-4.80 | · | · |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-350M | $-152M | · | $-171M | $-191M | $-189M | · | $-153M | $-120M | $-91M | · | $-57M | $-40M | $-35M | · | · | |
| Market Cap | $2.38B | $2.23B | · | $2.99B | $889M | $1.03B | · | $603M | $582M | $641M | · | $391M | $697M | $640M | · | · | |
| P/E | -6.5 | -13.8 | · | -12.8 | -3.8 | -4.2 | · | -3.7 | -4.3 | -5.9 | · | -3.0 | -4.4 | -3.3 | · | · | |
| P/B | 4.3 | 3.5 | · | 5.2 | 2.8 | 3.0 | · | 2.5 | 2.0 | 2.0 | · | 1.5 | 2.4 | 2.2 | · | · | |
| P / Tangible Book | 4.3 | 3.5 | · | 5.2 | 2.8 | 3.0 | · | 2.5 | 2.0 | 2.0 | · | 1.5 | 2.4 | 2.2 | · | · | |
| P / Cash Flow | · | -56.6 | · | · | · | -22.6 | · | · | · | -33.5 | · | · | · | -50.1 | · | · | |
| Earnings Yield | -15.4% | -7.3% | · | -7.8% | -26.5% | -23.6% | · | -26.9% | -23.1% | -16.9% | · | -32.9% | -22.6% | -30.6% | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Laba Bersih | $-155M | $-178M | $-72M | $-30M |
| EPS Dilusian | $-2.29 | $-3.66 | $-1.99 | $-5.77 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Rasio Lancar | 43.8 | 14.0 | 23.8 | · |
| Rasio Cepat | 11.4 | 7.8 | 4.7 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Arus Kas Bebas | $-142M | $-166M | · | · |
Pemilik institusional (13F) 246 pengaju · $2.8B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
246
Nilai yang dipegang
$2.8B
Posisi baru
38
Posisi yang keluar
22
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 38 (+1 vs Kuartal sebelumnya) | 22 (-14 vs Kuartal sebelumnya) | 89 (-15 vs Kuartal sebelumnya) | 70 (+16 vs Kuartal sebelumnya) | +4.5M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Catalys Pacific, LLC | $213.245.549 | 7.903.838 | 7,51% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $207.550.395 | 7.692.750 | 7,31% | Saham |
| BlackRock, Inc. | $158.832.288 | 5.887.038 | 5,59% | Saham |
| SAMSARA BIOCAPITAL, LLC | $158.400.066 | 5.871.018 | 5,58% | Saham |
| FMR LLC | $121.725.382 | 4.511.689 | 4,29% | Saham |
| VANGUARD GROUP INC | $121.676.015 | 3.352.880 | 4,28% | Saham |
| STATE STREET CORP | $111.741.339 | 4.141.636 | 3,93% | Saham |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $106.786.840 | 3.958.000 | 3,76% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $74.377.655 | 2.756.770 | 2,62% | Saham |
| Laurion Capital Management LP | $67.615.981 | 2.506.152 | 2,38% | Saham |
| ORBIMED ADVISORS LLC | $56.935.894 | 2.110.300 | 2,00% | Saham |
| Capital World Investors | $53.895.437 | 1.997.607 | 1,90% | Saham |
| ARMISTICE CAPITAL, LLC | $46.837.280 | 1.736.000 | 1,65% | Saham |
| Troluce Capital Advisors LLC | $46.641.756 | 1.728.753 | 1,64% | Saham |
| FRANKLIN RESOURCES INC | $44.126.329 | 1.635.520 | 1,55% | Saham |
| ANDERA PARTNERS | $42.949.921 | 1.591.917 | 1,51% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $42.753.193 | 1.584.326 | 1,51% | Saham |
| SR One Capital Management, LP | $42.195.803 | 1.563.966 | 1,49% | Saham |
| BANK OF AMERICA CORP /DE/ | $40.619.658 | 1.505.547 | 1,43% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $39.659.818 | 1.469.971 | 1,40% | Saham |
| GOLDMAN SACHS GROUP INC | $39.355.079 | 1.458.676 | 1,39% | Saham |
| Pictet Asset Management Holding SA | $38.598.910 | 1.430.649 | 1,36% | Saham |
| Polar Capital Holdings Plc | $38.334.641 | 1.420.854 | 1,35% | Saham |
| MILLENNIUM MANAGEMENT LLC | $32.963.031 | 1.221.758 | 1,16% | Saham |
| Ghisallo Capital Management LLC | $30.352.500 | 1.125.000 | 1,07% | Saham |
| Invesco Ltd. | $29.440.036 | 1.091.180 | 1,04% | Saham |
| ALLIANCEBERNSTEIN L.P. | $28.919.686 | 1.067.541 | 1,02% | Saham |
| Logos Global Management LP | $28.329.000 | 1.050.000 | 1,00% | Saham |
| ARMISTICE CAPITAL, LLC | $28.059.200 | 1.040.000 | 0,99% | Opsi beli |
| AMERICAN CENTURY COMPANIES INC | $27.972.049 | 1.036.767 | 0,99% | Saham |
| MORGAN STANLEY | $24.746.440 | 917.213 | 0,87% | Saham |
| Davern Capital Partners, LP | $23.169.156 | 858.753 | 0,82% | Saham |
| Candriam S.C.A. | $23.100.611 | 857.037 | 0,81% | Saham |
| Caption Management, LLC | $22.976.168 | 851.600 | 0,81% | Opsi jual |
| Nantahala Capital Management, LLC | $22.136.577 | 820.481 | 0,78% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $21.765.199 | 806.716 | 0,77% | Saham |
| Affinity Asset Advisors, LLC | $20.235.000 | 750.000 | 0,71% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20.171.786 | 747.657 | 0,71% | Saham |
| TUDOR INVESTMENT CORP ET AL | $19.921.223 | 738.370 | 0,70% | Saham |
| Aberdeen Group plc | $18.595.560 | 689.235 | 0,65% | Saham |
| ALGERT GLOBAL LLC | $17.510.748 | 649.027 | 0,62% | Saham |
| Catalio Capital Management, LP | $17.502.520 | 648.722 | 0,62% | Saham |
| Pale Fire Capital SE | $16.573.382 | 614.284 | 0,58% | Saham |
| STEMPOINT CAPITAL LP | $16.260.468 | 602.686 | 0,57% | Saham |
| NORTHERN TRUST CORP | $14.879.227 | 551.491 | 0,52% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $14.062.408 | 521.216 | 0,50% | Saham |
| Rock Springs Capital Management LP | $13.083.978 | 484.951 | 0,46% | Saham |
| TWO SIGMA ADVISERS, LP | $12.835.773 | 353.700 | 0,45% | Saham |
| CITADEL ADVISORS LLC | $12.615.794 | 467.598 | 0,44% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $12.501.914 | 463.387 | 0,44% | Saham |
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×4 pengajuan | 8 Sep. 2025 | 9,90% | Amandemen | · | SEC |
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×4 pengajuan | 8 Sep. 2025 | 8,20% | Amandemen | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 15 orang dalam · 5 pejabat · 10 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jon Congleton | Chief Executive Officer | 30 Sep. 2026 S | 528.621 | 0 | 18 | $-16.816.291 |
| Adam Scott Levy | CFO and Secretary | 19 Feb. 2026 A | 48.538 | 0 | 12 | $-6.161.340 |
| Eric Warren | Chief Commercial Officer | 21 Sep. 2026 M | 38.400 | 0 | 4 | $-3.299.041 |
| James J. Ferguson III | Chief Medical Officer | 10 Agu 2026 A | 102.400 | 0 | 0 | $0 |
| David Malcom Rodman | Chief Medical Officer | 10 Agu 2026 M | 51.384 | 0 | 39 | $-14.414.343 |
| Brian Taylor Slingsby | Direktur | 22 Sep. 2026 S | 7.805.718 | 0 | 1 | $-3.005.459 |
| Daphne Karydas | Direktur | 15 Sep. 2026 M | 6.200 | 0 | 5 | $-925.577 |
| Alexander M Gold | Direktur | 19 Feb. 2026 A | 6.200 | 0 | 5 | $-1.576.095 |
| Derek Dirocco | Direktur | 19 Feb. 2026 A | 6.200 | 0 | 0 | $0 |
| Glenn Sblendorio | Direktur | 19 Feb. 2026 A | 6.200 | 0 | 0 | $0 |
| Srinivas Akkaraju | Direktur | 19 Feb. 2026 A | 6.200 | 0 | 0 | $0 |
| Olivier Litzka | Direktur | 22 Mei 2024 A | · | 0 | 0 | $0 |
| Takeshi Takahashi | Direktur | 12 Juli 2023 J | · | 0 | 0 | $0 |
| Alexander Asam | Direktur | 9 Feb. 2023 A | · | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | Pemilik 10% | 14 Feb. 2023 C | 3.218.106 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 34 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,72% | 13.159 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,49% | 95.578 NS | 31 Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,15% | 6.241 SH | 1 Okt. 2026 | Harian |
| ESSC · Strategy Shares | 0,14% | 2.032 NS | 31 Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,14% | 1.306 NS | 31 Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,13% | 463.531 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,11% | 539.259 SH | 11 Sep. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,09% | 61.529 SH | 19 Agu 2026 | Harian |
| FFSM · FIDELITY COVINGTON TRUST | 0,07% | 39.638 NS | 31 Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,06% | 2.015 NS | 31 Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 54.668 SH | 11 Sep. 2026 | Harian |
| IWM · iShares Trust | 0,06% | 1.467.908 SH | 11 Sep. 2026 | Harian |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 14.976 NS | 31 Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,05% | 17.557 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 330.253 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,05% | 27.415 NS | 31 Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 29.046 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,03% | 156.005 NS | 31 Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 26.449 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 728.233 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,02% | 167.502 SH | 19 Agu 2026 | Harian |
| WSML · iShares Trust | 0,01% | 3.294 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 13.253 SH | 1 Okt. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,00% | 92.862 NS | 31 Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 3.792 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.224 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 92.513 SH | 11 Sep. 2026 | Harian |
| DFAU · Dimensional ETF Trust | 0,00% | 13.064 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 17.729 SH | 11 Sep. 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 19.954 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.968.124 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.746 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 2.439 SH | 11 Sep. 2026 | Harian |
| SMLF · iShares Trust | · | 93.121 SH | 11 Sep. 2026 | Harian |
MLYS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 16 analis
BELI
Target median
$52.00
+120,1%
5 31,2%
Beli Kuat
9 56,2%
Beli
2 12,5%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
8 analis · 2026-10-03Target rata-rata $48.50 +105,2%
← Di bawah semua target
Harga saat ini $23.63
Rendah$30.00
Rata-rata$48.50
Tinggi$56.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | · |
| VERA | · | -10.9 | · | · | -55.9% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Mineralys Therapeutics (MLYS) to Repurchase Potential Royalties for Lorundrostat
Yahoo Finance · 3 bulan, 2 minggu lalu
Apakah Mineralys Therapeutics, Inc. (MLYS) Saham yang Bagus untuk Dibeli Sekarang?
Yahoo Finance · 4 bulan, 4 minggu lalu
Aktivitas Opsi Hari Selasa yang Patut Diperhatikan: MLYS, DELL, SGHC
Nasdaq · 6 bulan lalu
Matematikanya Menunjukkan FTLS Dapat Naik ke $84
Nasdaq · 6 bulan, 1 minggu lalu
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Tidak ada sinyal terbuka saat ini — tidak ada kartu yang terisi, dan itu jujur.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 11, 2026